Literature DB >> 29070585

NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.

Peipei Luan1, Jianhui Zhuang2, Jun Zou3, Hailing Li2, Ping Shuai4, Xiaopeng Xu2, Yifan Zhao2, Wenxin Kou2, Shuya Ji2, Ai Peng5, Yawei Xu2, Qing Su1, Weixia Jian1, Wenhui Peng2.   

Abstract

NOD-like receptor family caspase recruitment domain family domain containing 5 (NLRC5) has important roles in inflammation and innate immunity. NLRC5 was highly expressed in kidney from streptozotocin-induced diabetic mice, db/ db mice and patients with diabetes. Based on that evidence, the present study was designed to explore the roles of NLRC5 in the progression of diabetic nephropathy (DN). We examined kidney injury, including inflammation and fibrosis in Nlrc5 gene knockout ( Nlrc5-/-) and wild-type (WT) diabetic mice. We found that Nlrc5-/- mice developed less-severe diabetic kidney injury compared with WT mice, exhibiting lower albuminuria, less fibronectin and collagen IV expression, and reduced macrophage infiltration but greater levels of podocin and nephrin in the diabetic kidney. The underlying mechanisms were further investigated in vitro with peritoneal macrophages and mesangial cells treated with high glucose. Reduced proinflammatory effect was observed in peritoneal macrophages from Nlrc5-/- mice, associated with NF-κB pathway suppression. Knocking down of NLRC5 in mesangial cells in high-glucose conditions was also associated with reduced NF-κB and TGF-β/Smad signaling. Taken together, NLRC5 promotes inflammation and fibrosis during DN progression partly through the effects on NF-κB and TGF-β/Smad pathways. NLRC5 may, therefore, be a promising therapeutic target for DN treatment.-Luan, P., Zhuang, J., Zou, J., Li, H., Shuai, P., Xu, X., Zhao, Y., Kou, W., Ji, S., Peng, A., Xu, Y., Su, Q., Jian, W., Peng, W. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.

Entities:  

Keywords:  albuminuria; diabetes; innate immunity; kidney injury; macrophages

Mesh:

Substances:

Year:  2018        PMID: 29070585     DOI: 10.1096/fj.201700511RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  14 in total

Review 1.  Roles of pattern recognition receptors in diabetic nephropathy.

Authors:  Zhi-Feng Zhou; Lei Jiang; Qing Zhao; Yu Wang; Jing Zhou; Qin-Kai Chen; Jin-Lei Lv
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

2.  Genetic manipulation of stress pathways can protect stem-cell-derived islets from apoptosis in vitro.

Authors:  Nayara C Leite; Gabriela C Pelayo; Douglas A Melton
Journal:  Stem Cell Reports       Date:  2022-03-03       Impact factor: 7.294

3.  The expression of NOD2, NLRP3 and NLRC5 and renal injury in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Luo-Yi Wang; Xiao-Jing Sun; Min Chen; Ming-Hui Zhao
Journal:  J Transl Med       Date:  2019-06-11       Impact factor: 5.531

4.  NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ.

Authors:  Peipei Luan; Weixia Jian; Xu Xu; Wenxin Kou; Qing Yu; Handan Hu; Dali Li; Wei Wang; Mark W Feinberg; Jianhui Zhuang; Yawei Xu; Wenhui Peng
Journal:  Nat Commun       Date:  2019-06-28       Impact factor: 14.919

5.  NLRP2 Regulates Proinflammatory and Antiapoptotic Responses in Proximal Tubular Epithelial Cells.

Authors:  Marianna N Rossi; Antonia Pascarella; Valerio Licursi; Ivan Caiello; Anna Taranta; Laura R Rega; Elena Levtchenko; Francesco Emma; Fabrizio De Benedetti; Giusi Prencipe
Journal:  Front Cell Dev Biol       Date:  2019-10-24

6.  The subcellular redistribution of NLRC5 promotes angiogenesis via interacting with STAT3 in endothelial cells.

Authors:  Xu Xu; Yefei Shi; Peipei Luan; Wenxin Kou; Bo Li; Ming Zhai; Shuangjie You; Qing Yu; Jianhui Zhuang; Weixia Jian; Mark W Feinberg; Wenhui Peng
Journal:  Theranostics       Date:  2021-03-04       Impact factor: 11.556

7.  Network Pharmacology-Based Prediction of Mechanism of Shenzhuo Formula for Application to DKD.

Authors:  Xinmiao Wang; Haoyu Yang; Lili Zhang; Lin Han; Sha Di; Xiuxiu Wei; Haoran Wu; Haiyu Zhang; Linhua Zhao; Xiaolin Tong
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-17       Impact factor: 2.629

8.  NLRC5: potential novel non-invasive biomarker for predicting and reflecting the progression of IgA nephritis.

Authors:  Yusa Chen; Huihui Li; Chenggen Xiao; Xiangli Zeng; Xiangcheng Xiao; Qiaoling Zhou; Ping Xiao
Journal:  J Transl Med       Date:  2018-11-19       Impact factor: 5.531

9.  Celastrol slows the progression of early diabetic nephropathy in rats via the PI3K/AKT pathway.

Authors:  Yusong Nie; Chengxiao Fu; Huimin Zhang; Min Zhang; Hui Xie; Xiaopei Tong; Yao Li; Zhenyan Hou; Xinrong Fan; Miao Yan
Journal:  BMC Complement Med Ther       Date:  2020-10-23

Review 10.  New Insights into the Mechanisms of Pyroptosis and Implications for Diabetic Kidney Disease.

Authors:  Jinwen Lin; Ao Cheng; Kai Cheng; Qingwei Deng; Shouzan Zhang; Zehao Lan; Weidong Wang; Jianghua Chen
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.